Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Bayer Ag ADR (OP:BAYRY)

11.79 +0.08 (+0.68%)

Streaming Delayed Price Updated: 3:58 PM EDT, Apr 9, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,137,453
Open	11.68
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	11.71
Today's Range	11.65 - 11.86
52wk Range	5.360 - 14.85
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Bayer Announces Leadership Change Within Pharmaceuticals’ Worldwide Markets Organization in the U.S. to Support Company’s Full Growth Potential

March 31, 2026

From Bayer

Via Business Wire

Multiplatinum Rapper, Actor Ludacris Partners with One A Day® to Help People Realize that Health Does Not Need to Be Ludacris

March 26, 2026

From Bayer

Via Business Wire

Performance

YTD	+6.3%	+6.3%
1 Month	+3.8%	+3.8%
3 Month	+3.0%	+3.0%
6 Month	+45.7%	+45.7%
1 Year	+105.8%	+105.8%

More News

The Great Unbundling: How AI’s Insatiable Hunger is Driving a Corporate Divestiture Gold Rush

March 18, 2026

Via MarketMinute

KERENDIA® (finerenone) Meets Primary Endpoint in Investigational Phase III FIND-CKD Study in Patients with Non-Diabetic Chronic Kidney Disease

March 16, 2026

From Bayer

Via Business Wire

New FDA 510(k) Clearance Expands Bayer’s MEDRAD® MRXperion MR Injection System Support Across Diverse Range of MR Environments

March 04, 2026

From Bayer

Via Business Wire

The Section 122 Pivot: How a 10% Global Tariff is Reshaping the 2026 Market Landscape

March 03, 2026

Via MarketMinute

The Strategic Crossroads of FMC Corporation: A 2026 Research Deep Dive

March 03, 2026

Via Finterra

The Great Grain Pivot: USDA Forecasts Record Soy Surge as Corn Retreats in 2026

March 02, 2026

Via MarketMinute

Bayer Reports Results for the Investigational Targeted Radionuclide Therapy 225Ac-PSMA-Trillium in Advanced Metastatic Prostate Cancer

February 27, 2026

From Bayer

Via Business Wire

Bayer’s XOFIGO® (radium-223 dichloride) Plus Enzalutamide Demonstrates Significant Overall Survival Benefit in PEACE-3 Trial in Patients With Metastatic Castration-Resistant Prostate Cancer With Bone Metastases

February 26, 2026

From Bayer

Via Business Wire

European Commission Grants Marketing Authorization to Cytokinetics for Cardiac Drug MYQORZO

February 23, 2026

Via MarketMinute

Bayer Alleges J&J’s Claims Regarding NUBEQA® are Deeply Flawed and Intentionally Aimed at Boosting Sales of J&J’s ERLEADA

February 23, 2026

From Bayer

Via Business Wire

Bayer's $7.25 Billion Roundup Settlement: A 21-Year Plan for Certainty

February 18, 2026

Via MarketMinute

Uncle Sam’s $44.36 Per Acre Gamble: How Government Intervention is Distorting the 2026 Planting Season

February 18, 2026

Via MarketMinute

German Pharma Giant Bayer Proposes $7.25 Billion Settlement Over Monsanto's Roundup Cancer Claims In US ↗

February 18, 2026

Via Benzinga

Retina’s ‘Sustained’ Moment: Ocular Therapeutix Braces for Game-Changing Phase 3 AXPAXLI Data

February 16, 2026

Via MarketMinute

Bayer® Aspirin Partners with Celebrity Chef Jeff Mauro for Immersive Dark Dining Experience This American Heart Month

February 12, 2026

From Bayer

Via Business Wire

Bayer’s Asundexian Demonstrated a Substantial 26% Reduction in Stroke After a Non-Cardioembolic Ischemic Stroke or High-Risk Transient Ischemic Attack, With No Increase in ISTH Major Bleeding Versus Placebo

February 05, 2026

From Bayer

Via Business Wire

Bayer Teams Up with Former Professional Quarterback Tony Romo on ‘Highlights REAL’ Campaign

January 29, 2026

From Bayer

Via Business Wire

Bayer to Present Results From Phase III OCEANIC-STROKE Study of Asundexian in Secondary Stroke Prevention

January 27, 2026

From Bayer

Via Business Wire

Wall Street’s ‘Fear Gauge’ Reclaims the 20 Mark: Why the Greenland Tariff Threat and Earnings Redlining Triggered a Market Reset

January 20, 2026

Via MarketMinute

Bayer and Vanderbilt University Medical Center to Advance Treatments for Cardiovascular and Kidney Diseases

January 20, 2026

From Bayer

Via Business Wire

The mRNA 2.0 Inflection: A Deep Dive into Moderna (MRNA) as it Faces a Critical 2026

January 16, 2026

Via Finterra

Bayer Accelerates Pharma Growth on High-Value Portfolio

January 13, 2026

From Bayer

Via Business Wire

Actress and Menopause Advocate Gabrielle Union-Wade Partners with Bayer in the Lynkuet® (elinzanetant) ‘Life Doesn’t Stop for a Hot Flash’ Campaign for Moderate to Severe Hot Flashes Due to Menopause

January 13, 2026

From Bayer

Via Business Wire

Frequently Asked Questions

Is Bayer Ag ADR publicly traded?

Yes, Bayer Ag ADR is publicly traded.

What exchange does Bayer Ag ADR trade on?

Bayer Ag ADR trades on the OTC Traded

What is the ticker symbol for Bayer Ag ADR?

The ticker symbol for Bayer Ag ADR is BAYRY on the OTC Traded

What is the current price of Bayer Ag ADR?

The current price of Bayer Ag ADR is 11.79

When was Bayer Ag ADR last traded?

The last trade of Bayer Ag ADR was at 04/09/26 03:58 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.